| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.6M | -18.2% | +29.0% |
| R&D Expense | $1.2M | +0.0% | -7.7% |
| SG&A Expense | $6.4M | +19.6% | -3.7% |
| Operating Income | -$8.1M | -28.6% | +29.7% |
| Pre-tax Income | $4.1M | +161.1% | +134.6% |
| Income Tax | $119K | +397.5% | -57.7% |
| Net Income | $4.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.3M | -13.1% | — |
| Accounts Receivable | $2.6M | +149.1% | — |
| Current Assets | $35.5M | -4.9% | — |
| Total Assets | $70.9M | -4.0% | — |
| Current Liabilities | $32.9M | -13.7% | — |
| Total Liabilities | $127.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.4M | — | — |
| Capital Expenditures | $4.0M | — | — |
| Investing Cash Flow | -$4.0M | — | — |
| Financing Cash Flow | $27.0M | — | — |
| Free Cash Flow | -$21.5M | — | — |
| +159.6% |
| +132.8% |
| EPS (Basic) | $0.04 | +166.7% | +130.8% |
| EPS (Diluted) | -$0.02 | +66.7% | +84.6% |
| -10.0% |
| — |
| Stockholders' Equity | -$56.9M | +16.5% | -832.2% |